ATE239463T1 - Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein - Google Patents

Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein

Info

Publication number
ATE239463T1
ATE239463T1 AT00920520T AT00920520T ATE239463T1 AT E239463 T1 ATE239463 T1 AT E239463T1 AT 00920520 T AT00920520 T AT 00920520T AT 00920520 T AT00920520 T AT 00920520T AT E239463 T1 ATE239463 T1 AT E239463T1
Authority
AT
Austria
Prior art keywords
acetylcystone
high content
swallowable tablets
acetylcysteine
weight
Prior art date
Application number
AT00920520T
Other languages
English (en)
Inventor
Franco Castegini
Alessandro Grassano
Riccardo Barina
Italo Zuliani
Giovanni Gurrieri
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE239463T1 publication Critical patent/ATE239463T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT00920520T 1999-04-06 2000-03-21 Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein ATE239463T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000704A IT1311907B1 (it) 1999-04-06 1999-04-06 Compresse deglutibili ad alto contenuto di n-acetilcisteina.
PCT/EP2000/002464 WO2000059500A1 (en) 1999-04-06 2000-03-21 Swallowable tablets with high content of n-acetylcysteine

Publications (1)

Publication Number Publication Date
ATE239463T1 true ATE239463T1 (de) 2003-05-15

Family

ID=11382595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00920520T ATE239463T1 (de) 1999-04-06 2000-03-21 Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein

Country Status (15)

Country Link
EP (1) EP1165065B1 (de)
CN (1) CN1159004C (de)
AT (1) ATE239463T1 (de)
AU (1) AU4106800A (de)
BR (1) BR0008657A (de)
CA (1) CA2361843C (de)
CO (1) CO4970828A1 (de)
DE (1) DE60002570T2 (de)
DK (1) DK1165065T3 (de)
EA (1) EA003878B1 (de)
ES (1) ES2197087T3 (de)
HU (1) HU228823B1 (de)
IT (1) IT1311907B1 (de)
PT (1) PT1165065E (de)
WO (1) WO2000059500A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US7993578B2 (en) 2004-10-29 2011-08-09 Depuy Spine, Inc. Methods and kits for aseptic filling of products
PL2407166T3 (pl) * 2009-03-13 2014-01-31 Toyama Chemical Co Ltd Tabletka i granulowany proszek zawierające 6-fluoro-3-hydroksy-2-pirazynokarboksamid
CN102573463A (zh) * 2009-07-15 2012-07-11 小利兰·斯坦福大学托管委员会 N-乙酰半胱氨酸组合物以及改善对乙酰氨基酚的治疗效能的方法
IT1399492B1 (it) 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN102028657B (zh) * 2010-12-02 2012-05-23 海南美兰史克制药有限公司 乙酰半胱氨酸脂质体固体制剂
CN102144978B (zh) * 2011-04-11 2013-03-13 南京正科制药有限公司 一种乙酰半胱氨酸颗粒及其制备工艺
CN102743369A (zh) * 2012-06-19 2012-10-24 苏州朗易生物医药研究有限公司 一种乙酰半胱氨酸的药物组合物及其制备方法
ITMI20130874A1 (it) * 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina
CN104784116B (zh) * 2015-04-15 2017-05-24 武汉诺贝药业有限公司 一种n‑乙酰半胱氨酸口服制剂
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
US20250235416A1 (en) * 2017-09-20 2025-07-24 Nacuity Pharmaceuticals, Inc. Method for preparation of n-acetyl cysteine amide, derivatives and tablets thereof
CN110292569B (zh) * 2019-07-15 2021-11-02 广东人人康药业有限公司 一种乙酰半胱氨酸胶囊及其制备方法
CN112843008A (zh) * 2021-02-07 2021-05-28 广东赛康制药厂有限公司 一种乙酰半胱氨酸片及其制备方法
CN117919218A (zh) * 2024-02-01 2024-04-26 浙江金华康恩贝生物制药有限公司 一种乙酰半胱氨酸药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315249A1 (de) * 1987-11-02 1989-05-10 Merck & Co. Inc. Phthalazinessigsäure-Zusammensetzung und Tablette
DE59106133D1 (de) * 1990-10-19 1995-09-07 Spirig Ag Feste, schnell-lösliche Arzneimittelzubereitung enthaltend S-(Carboxymethyl)-L-Cystein und/oder N-Acetylcystein.
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
AU4106800A (en) 2000-10-23
ITMI990704A1 (it) 2000-10-06
DK1165065T3 (da) 2003-09-01
EP1165065B1 (de) 2003-05-07
PT1165065E (pt) 2003-08-29
WO2000059500A1 (en) 2000-10-12
DE60002570T2 (de) 2004-02-26
CN1345236A (zh) 2002-04-17
ES2197087T3 (es) 2004-01-01
IT1311907B1 (it) 2002-03-20
CN1159004C (zh) 2004-07-28
HU228823B1 (en) 2013-05-28
CA2361843C (en) 2008-10-14
BR0008657A (pt) 2001-12-18
DE60002570D1 (de) 2003-06-12
HUP0200646A2 (hu) 2002-07-29
EP1165065A1 (de) 2002-01-02
EA200100947A1 (ru) 2002-04-25
CA2361843A1 (en) 2000-10-12
CO4970828A1 (es) 2000-11-07
EA003878B1 (ru) 2003-10-30

Similar Documents

Publication Publication Date Title
DE60002570D1 (de) Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein
GEP20063799B (en) Tropane derivatives useful in therapy
NO20062098L (no) Faststofftilstandmontelukast
DE60028754D1 (de) Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
AP1637A (en) Celecoxib compositions.
CA2239174A1 (en) Novel compounds with analgesic effect
EG25822A (en) Quinolinyl-pyrrolopyrazoles
SE1755590T5 (de)
GB8817015D0 (en) Method of treatment
DE69033970D1 (de) Huperzin a analoge verbindungen
ECSP003807A (es) Composiciones valdecoxib
DK616186D0 (da) Farmaceutisk praeparat med retarderet frigivelse af ibuprofen
DE60010316D1 (de) Magnesiumomeprazol
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
IL72900A0 (en) Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
CA2595363A1 (en) Methods and materials with trans-clomiphene for the treatment of male infertility
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
GB984517A (en) New derivatives of 5-amino-isoindoline
AU2003229202A1 (en) Compositions comprising hepoxilin analogs and their use in the treatment of cancer
UA4344U (uk) Спосіб лікування дітей з helicobacter pylori-асоційованим гастродуоденітом та хронічною рецидивуючою кандидо-герпетичною інфекцією
MX9804797A (es) Nuevos compuestos con efecto analgesico.
UA4346U (uk) Спосіб лікування дітей з helicobacter pylori-асоційованим гастродуоденітом та рецидивуючою герпетичною інфекцією
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
JPS562914A (en) Preventive and remedy for mycosis of shrimp
JPS5486628A (en) Analgesic antiphlogistic agent

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165065

Country of ref document: EP